nerve biopsy performed in our department and who satisfied the diagnostic criteria for CIDP,278 had cranial MRI on a General Electric Signa 1 5 Tesla unit at the Royal North Shore Hospital in Sydney. Patients were selected on the basis of availability. Sagittal partial saturation images were made with a repetition time (TR) of 600 ms and an echo-delay time (TE) of 20 ms. Axial spin-echo images were sequenced with a TR of2600 ms and a TE of 30 and 80 ms. The images were interpreted blind by a neuroradiologist (JH) and assessed for white matter signal changes. Areas of increased signal were not regarded as significant if they were: <2 mm in largest diameter, considered to be normal patterns or degraded by artifact. Attention was given to the distribution of white matter signal changes.
Results
Clinicalfeatures (table 1) There were 21 patients with CIDP (17 male, four female). The mean age at onset was 42 years (range 16-74; SD 13 years). The mean age at the time of MRI was 52 years (range 34-78; SD 11 years). Twelve patients had relapsing disease and nine had a non-relapsing course. The disease was considered active using the criteria described above in eight patients and inactive in 13 patients. Most patients had mild to moderate disability when MRI was performed.
There were five patients in whom the demyelinating neuropathy was associated with benign monoclonal gammopathy (IgGk = two patients; IgMA = three patients). The clinical characteristics were similar to those without paraproteinaemia. The mean age at onset was 57 years (range 23-70; SD 21) years. The mean age at the time of MRI was 65 years (range 33-79; SD 19 years). Three patients had a relapsing and two patients a non-relapsing course. All patients had active disease at the time of MRI. Hawke, Hallinan Although there were no age-matched controls included in our study, there are now data available in the published literature that clearly show an increased frequency of white matter signal abnormalities with increasing age in healthy subjects.'""
In a study using a 1-5 Tesla magnet, Fazekas et al'2 found parenchymal white matter signal changes in 27 of 44 healthy volunteers free of cerebrovascular symptoms. Awad et al 3 found that incidental white matter signal changes seen at necropsy MRI in seven elderly patients dying of non-neurological disease were due to sub-cortical atherosclerosis. It is likely therefore that white matter changes visualised in elderly patients are the results of vascular disease rather than of primary demyelination.
Criteria have recently been suggested in order to increase the specificity of MRI in demyelinating disease in older age groups.9
Using these criteria for primary demyelination (that is, two or more of the following findings: (a) lesion size > 6 mm; (b) lesions abutting the bodies of the lateral ventricles; and (c) infratentorial white matter lesions), only one of the patients over 50 years old in this study would have had a scan indicating demyelination (case 20, who fulfilled criteria a and b).
In the group of younger patients, in which the most conclusive information to support the existence of concurrent central and peripheral nerve demyelination is likely to be found, MRI was abnormal in only one patient in whom a single area of increased white matter signal was imaged. In a series of younger control subjects abnormalities have been found in small numbers.'4 Although some authors have viewed the occurrence of white matter changes in younger healthy subjects as indicative of sub-clinical demyelination6 there is no pathological data to support this contention and thus the nature of these lesions is unproven.
Thomas et al 4 reported six cases in which a chronic demyelinating neuropathy was associated wit.h a relapsing multifocal CNS disorder resembling multiple sclerosis. In the five patients in whom it was performed, MRI showed lesions indistinguishable from those observed in MS. Rubin et al3 also reported two patients with CIDP with clinical evidence of CNS demyelination. In the patient in whom it was performed, MRI demonstrated multiple periventricular and brainstem abnormalities. 
